Radiotherapy & Oncology
Volume 94, Issue 1 , Pages 24-29 , January 2010

I-125 seed planning: An alternative method of urethra definition

Received 23 December 2008 ,Revised 2 November 2009 ,Accepted 9 November 2009.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2007. CA Cancer J Clin. 2007;57:43–66
  2. Parkin DM, Bray F, Ferley J, et al. Global cancer statistics. CA Cancer J Clin. 2005;55:74–108
  3. Sloboda R, Pedersen J. The importance of urethral visualization for preplanned permanent prostate implants. Brachytherapy. 1995;4:195–201
  4. Salembier C, Lavagnini P, Nickers P, et al. Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol. 2007;83:3–10
  5. Wallner K, Roy J, Harrison M. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1995;32:465–471
  6. Merrick G, Butler W, Tollenaar B, et al. The dosimetry of prostate brachytherapy-induced urethral strictures. Int J Radiat Oncol Biol Phys. 2002;52:461–468
  7. Rivard MJ, Coursey BM, DeWerd LA, et al. Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations. Med Phys. 2004;31:633–674
  8. Baltas D, Kolotas C, Geramani K, et al. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys. 1998;40:515–524
  9. ICRU Report No. 50. Prescribing, recording and reporting photon beam therapy; 1993.
  10. ICRU Report No. 62. A supplement to ICRU 50; 1999.
  11. Mitchell D, Mandall P, Bottomley D, et al. Report on the early efficacy and tolerability of I-125 permanent prostate brachytherapy from a UK multi-institutional database. Clin Oncol. 2008;20:738–744
  12. Dogan N, Mohideen N, Glasgow G, et al. Effect of prostatic edema on CT-based postimplant dosimetry. Int J Radiat Oncol Biol Phys. 2002;53:483–489
  13. Roberson P, Narayana V, McShan D, et al. Source placement error for permanent implant of the prostate. Med Phys. 1997;24:251–257
  14. Al-Qaisieh B. Pre- and post-implant dosimetry: an intercomparison between UK prostate brachytherapy centres. Radiother Oncol. 2003;66:181–183
  15. Al-Qaisieh B, Ash D, Bottomley D, et al. Impact of prostate volume evaluation by different observers on CT-based post implant dosimetry. Radiother Oncol. 2002;62:267–273
  16. Tanaka O, Hayashi S, Matsuo M, et al. MRI-based preplanning in low-dose-rate prostate brachytherapy. Radiother Oncol. 2008;88:115–120
  17. Millar J, Longano A, Imbert S, et al. A simple technique for determining accurate urethral dosimetry after seed brachytherapy for prostate cancer. Brachytherapy. 2006;5:27–31

PII: S0167-8140(09)00615-X

doi: 10.1016/j.radonc.2009.11.003

Radiotherapy & Oncology
Volume 94, Issue 1 , Pages 24-29 , January 2010